NCT02034071View on ClinicalTrials.gov

Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Prader-Willi Syndrome
Interventions
DRUG

DCCR

DRUG

Placebo

Trial Locations (1)

92686

University of California, Irvine, Orange

All Listed Sponsors
lead

Essentialis, Inc.

INDUSTRY

NCT02034071 - Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter